NASH Stocks on Watch after Allergan Acquires Tobira at Massive Premium

September 20, 2016 8:12 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

A number of NASH stock are seeing upside after Allergan plc (NYSE: AGN) agreed to acquire Tobira Therapeutics, Inc. (NASDAQ: TBRA) for an upfront payment of $28.35 per share, in cash, and up to $49.84 per share in Contingent Value Rights (CVRs). Shares closed at $4.74 yesterday.

Stocks on watch:

Conatus Pharmaceuticals (NASDAQ: CNAT)
Galectin Therapeutics (NASDAQ: GALT)
Galmed Pharma (NASDAQ: GLMD)
Intercept Pharma (NASDAQ: ICPT)

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Rumors, Trader Talk

Related Entities

Definitive Agreement

Add Your Comment